Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,166,817 papers from all fields of science
Search
Sign In
Create Free Account
RMP-7
Known as:
L-Prolinamide,L-Arginyl-L-protyl-trans-4-hydroxy-L-prolyl-3-(2-thienyl)-L-alanylglycyl-L-seryl-N-02-004-0(aminoiminomethyl)amino)-1-0(4-methoxyphenyl)methyl)ethyl)-,0S-(R*,R*))
, L-Prolinamide, L-arginyl-L-prolyl-trans-4-hydroxy-L-prolyl-3-(2-thienyl)-L-alanylglycyl-L-seryl-N-02-004-0((((aminoiminomethyl)amino)-1-carboxybutyl)amino)-1-0(((4-methoxyphenyl)methyl)ethyl)-, 0S-(R*,R*)-
, RMP 7
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Broader (1)
Bradykinin
Narrower (2)
Cereport
labradimil
analogs & derivatives
carboplatin/lobradimil
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Investigation of Elimination Rate, Persistent Subpopulation Removal, and Relapse Rates of Mycobacterium tuberculosis by Using Combinations of First-Line Drugs in a Modified Cornell Mouse Model
Yanmin Hu
,
H. Pertinez
,
+5 authors
A. Coates
Antimicrobial Agents and Chemotherapy
2016
Corpus ID: 18879872
ABSTRACT Currently, the most effective tuberculosis control method involves case finding and 6 months of chemotherapy. There is a…
Expand
2015
2015
Novel benzidine and diaminofluorene prolinamide derivatives as potent hepatitis C virus NS5A inhibitors.
Il Hak Bae
,
Heesun Kim
,
+7 authors
B. Moon Kim
European journal of medicinal chemistry
2015
Corpus ID: 23261899
2004
2004
Intra-arterial administration of carboplatin and the blood brain barrier permeabilizing agent, RMP-7: A toxicologic evaluation in swine
M. Riley
,
Norman N. Kim
,
+4 authors
R. Bartus
Journal of Neuro-Oncology
2004
Corpus ID: 4946494
RMP-7 is a bradykinin B2 receptor agonist shown to permeabilize the blood-brain barrier, especially that associated with brain…
Expand
2001
2001
Antithrombotic effects of YS-49 and YS-51--1-naphthylmethyl analogs of higenamine.
H. Yun-Choi
,
M. Pyo
,
K. Park
,
K. C. Chang
,
D. H. Lee
Thrombosis Research
2001
Corpus ID: 23735671
2001
2001
The Malta Project – A Country Freed Itself of Leprosy
E. Freerksen
,
M. Rosenfeld
,
G. Depasquale
,
E. Bonnici
,
P. Gatt
Chemotherapy
2001
Corpus ID: 46187062
The successful conclusion of the first leprosy eradication program carried out with combination therapy is reported. This program…
Expand
1997
1997
RMP-7
A. Boddy
,
H. Thomas
CNS Drugs
1997
Corpus ID: 209144092
SummaryThe chemotherapy of tumours located in the brain is far from satisfactory, with very poor response rates even with tumour…
Expand
1995
1995
Posatirelin for the treatment of late‐onset Alzheimer's disease: a double‐blind multicentre study vs citicoline and ascorbic acid
L. Parnetti
,
L. Ambrosoli
,
+16 authors
U. Senin
Acta Neurologica Scandinavica
1995
Corpus ID: 36833784
Introduction ‐ Posatirelin (L‐pyro‐2–aminoadipyl‐L‐leucil‐L‐prolinamide) a new synthetic tripeptide with cholinergic…
Expand
1995
1995
Inhibition of human neutrophil elastase. 3. An orally active enol acetate prodrug.
J. P. Burkhart
,
J. R. Koehl
,
+7 authors
P. Shum
Journal of Medicinal Chemistry
1995
Corpus ID: 34584132
Several analogs of N-[4-(4-morpholinylcarbonyl)benzoyl]-L-valyl-N-[3,3,4,4,4-penta fluoro-1- (1-methylethyl)-2-oxobutyl]-L…
Expand
1995
1995
RMP-7, a bradykinin agonist, increases permeability of blood-ocular barriers in the guinea pig.
P. Elliott
,
J. Mackic
,
W. Graney
,
R. Bartus
,
B. Zlokovic
Investigative Ophthalmology and Visual Science
1995
Corpus ID: 33057875
PURPOSE To determine if the bradykinin agonist, RMP-7, could increase the ocular tissue concentration of agents that normally…
Expand
1980
1980
Release of the chloride-dependent arginine aminopeptidase from PMN leukocytes and macrophages during phagocytosis.
E. Söderling
,
M. Knuuttila
Life Science
1980
Corpus ID: 45348076
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE